Skip to main content
. Author manuscript; available in PMC: 2021 Apr 1.
Published in final edited form as: Mol Imaging Biol. 2020 Apr;22(2):367–376. doi: 10.1007/s11307-019-01386-7

Figure 3.

Figure 3.

[89Zr]A2cDb immunoPET of hPSCA Ki mice. a In vivo [89Zr]A2cDb immunoPET (2–2.8 MBq/12–15 μg, i.v. tail vein) at 5 and 20 h post injection into hPSCA KI mice (n = 6) and C57BL/6J wild type mice (n = 4). Scans are displayed as whole-body MIP/CT overlays. b Ex vivo PET/CT scans of normal PSCA-expressing tissues. hPSCA KI mice (left panels) showed slightly higher tracer uptake in the stomach compared with C57BL/6J wild type mice.